4//SEC Filing
Llorens Josep 4
Accession 0001127602-23-021080
CIK 0000313143other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:17 PM ET
Size
12.0 KB
Accession
0001127602-23-021080
Insider Transaction Report
Form 4
Llorens Josep
SVP, Global Manufacturing
Transactions
- Exercise/Conversion
Common Stock
2023-07-18$56.57/sh+2,391$135,259→ 20,854 total - Exercise/Conversion
Common Stock
2023-07-18$57.60/sh+2,537$146,131→ 23,391 total - Sale
Common Stock
2023-07-18$90.00/sh−4,928$443,520→ 18,463 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2023-07-18−2,537→ 7,611 totalExercise: $57.60From: 2023-05-16Exp: 2029-05-16→ Common Stock (2,537 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2023-07-18−2,391→ 4,782 totalExercise: $56.57From: 2022-05-18Exp: 2028-05-18→ Common Stock (2,391 underlying)
Footnotes (3)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001750812
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:17 PM ET
- Size
- 12.0 KB